Glen Eagle Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$74.8K Sell
956
-1,138
-54% -$89K 0.01% 359
2025
Q1
$152K Sell
2,094
-6,597
-76% -$478K 0.03% 270
2024
Q4
$643K Sell
8,691
-4,678
-35% -$346K 0.11% 120
2024
Q3
$882K Sell
13,369
-1,056
-7% -$69.7K 0.15% 107
2024
Q2
$1.33M Buy
14,425
+4,965
+52% +$459K 0.24% 76
2024
Q1
$904K Buy
9,460
+7,395
+358% +$707K 0.17% 100
2023
Q4
$157K Buy
2,065
+1,398
+210% +$107K 0.03% 250
2023
Q3
$46.2K Hold
667
0.01% 389
2023
Q2
$62.9K Hold
667
0.01% 349
2023
Q1
$55.2K Hold
667
0.01% 353
2022
Q4
$49.8K Hold
667
0.01% 361
2022
Q3
$55.1K Hold
667
0.02% 338
2022
Q2
$63.4K Hold
667
0.02% 335
2022
Q1
$78.5K Hold
667
0.02% 315
2021
Q4
$86.4K Hold
667
0.02% 300
2021
Q3
$75.5K Sell
667
-23
-3% -$2.6K 0.02% 311
2021
Q2
$71.5K Hold
690
0.02% 315
2021
Q1
$57.7K Hold
690
0.02% 323
2020
Q4
$62.9K Sell
690
-75
-10% -$6.84K 0.02% 294
2020
Q3
$61.1K Sell
765
-3
-0.4% -$239 0.03% 278
2020
Q2
$53.1K Buy
768
+78
+11% +$5.39K 0.03% 275
2020
Q1
$43.4K Sell
690
-99
-13% -$6.23K 0.03% 278
2019
Q4
$61.4K Buy
789
+3
+0.4% +$233 0.03% 290
2019
Q3
$57.6K Buy
786
+96
+14% +$7.04K 0.04% 268
2019
Q2
$42.5K Hold
690
0.03% 295
2019
Q1
$44K Hold
690
0.03% 278
2018
Q4
$35.2K Sell
690
-75
-10% -$3.83K 0.03% 280
2018
Q3
$44.4K Sell
765
-12
-2% -$696 0.03% 271
2018
Q2
$37.7K Sell
777
-3
-0.4% -$146 0.03% 285
2018
Q1
$36.3K Buy
780
+723
+1,268% +$33.6K 0.03% 281
2017
Q4
$2.14K Sell
57
-1,314
-96% -$49.4K ﹤0.01% 565
2017
Q3
$50K Buy
1,371
+771
+129% +$28.1K 0.05% 237
2017
Q2
$23.6K Buy
600
+75
+14% +$2.96K 0.02% 290
2017
Q1
$16.5K Buy
525
+150
+40% +$4.7K 0.01% 311
2016
Q4
$11.7K Buy
+375
New +$11.7K 0.01% 334